Postgrad Med J

Postgrad Med J find more 2005, 81:702–710.PubMedCrossRef 3. Hermanek P, Hutter RVP, Sobin LH, Wittekind C: Classification of isolated tumor cells and micrometastasis. Cancer 1999, 86:2668–2673.PubMedCrossRef 4. Raj GV, Moreno JG, Gomella LG: Utilization of polymerase chain reaction technology in the detection of solid tumors. Cancer 1998, 82:1419–1442.PubMedCrossRef 5. Slade MJ, Smith BM, Sinnett HD, Cross NC, Coombes RC:

Quantitative polymerase chain reaction for the detection of micrometastases in patients with breast cancer. J Clin Oncol 1999, 17:1330. 6. NCCN Clinical Practice Guidelines in Oncology. Version 3. 2012. [http://​www.​NCCN.​org] 7. World Health Organization: WHO Handbook for Reporting STI571 solubility dmso Results of Cancer Treatment. Geneva, Switzerland: WHO Offset Publication; 1979. No. 48 8. Li X, Asmitananda T, Gao L, Gai D, Song Z, Zhang Y, Ren H, Yang T, Chen T, Chen M: Biomarkers in the lung cancer diagnosis: a clinical perspective. Neoplasma 2012, 59:500–507.PubMedCrossRef 9. Schneider J: Tumor markers in detection of lung cancer. Adv Clin Chem 2006, 42:1–41.PubMedCrossRef 10. Sun SS, Hsieh JF, Tsai SC, Ho YJ, Lee JK, Kao CH: Cytokeratin fragment 19 and squamous cell carcinoma antigen for early prediction of recurrence of squamous cell lung carcinoma. Am J Clin Oncol 2000, 23:241–243.PubMedCrossRef 11. Schneider J, Velcovsky HG, Morr H, Katz N, Neu K,

Eigenbrodt E: Comparison of the tumor markers tumor M2-PK, CEA, CYFRA 21–1, NSE and SCC in the diagnosis of lung cancer. Anticancer Res 2000, 20:5053–5058.PubMed

12. Iwao K, Watanabe T, Fujiwara Y, Takami K, Kodama K, Higashiyama see more M, Yokouchi H, Ozaki K, Monden M, Tanigami A: Isolation of a novel human lung-specific gene, LUNX, a potential molecular marker for detection of micrometastasis in non-small-cell Morin Hydrate lung cancer. Int J Cancer 2001, 91:433–437.PubMedCrossRef 13. Lv M, Wu MZ, Zhao YJ, Yang DI, Wang EH, Wu GP: Expression and clinical significance of lung-specific X protein mRNA in bronchial brushing specimens from patients with or without lung cancer. Respirology 2011, 16:1076–1080.PubMedCrossRef 14. Mitas M, Hoover L, Silvestri G, Reed C, Green M, Turrisi AT, Sherman C, Mikhitarian K, Cole DJ, Block MI, Gillanders WE: Lunx is a superior molecular marker for detection of non-small cell lung cancer in peripheral blood [corrected]. J Mol Diagn 2003, 5:237–242.PubMedCrossRef 15. Wallace MB, Block MI, Gillanders W, Ravenel J, Hoffman BJ, Reed CE, Fraig M, Cole D, Mitas M: Accurate molecular detection of non-small cell lung cancer metastases in mediastinal lymph nodes sampled by endoscopic ultrasound-guided needle aspiration. Chest 2005, 127:430–437.PubMedCrossRef 16. Wang Y, Zhang Y, Du Z, Wu M, Zhang G: Detection of micrometastases in lung cancer with magnetic nanoparticles and quantum dots. Int J Nanomedicine. 2012, 7:2315–2324.PubMed 17.

Comments are closed.